Although there is greater secretion of both types of ACE2 (i.e., as enzyme in plasma and as receptor in cardiovascular tissues) in patients with cardiovascular diseases, SARS-CoV-2 might also increase cardiovascular tissue expression of ACE2 in others [27, 28]. The gene discussed is ACE2; the disease is cardiovascular disorder.